Public Profile

Fresenius Kabi Canada Ltd.

Fresenius Kabi Canada Ltd., a subsidiary of the global healthcare group Fresenius Kabi, is headquartered in Canada and operates extensively across the country. Founded in 1999, the company has established itself as a key player in the pharmaceutical and medical device industry, focusing on lifesaving medicines and technologies. Fresenius Kabi is renowned for its comprehensive portfolio, which includes intravenous (IV) drugs, infusion therapies, and clinical nutrition products. These offerings are distinguished by their commitment to quality and innovation, ensuring optimal patient care. With a strong market position, Fresenius Kabi Canada has achieved notable milestones, including advancements in biosimilars and a robust supply chain that supports healthcare providers nationwide.

DitchCarbon Score

How does Fresenius Kabi Canada Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Fresenius Kabi Canada Ltd.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Fresenius Kabi Canada Ltd.'s reported carbon emissions

Fresenius Kabi Canada Ltd., headquartered in CA, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete emissions figures or defined reduction strategies, it is challenging to assess their current environmental impact or commitments to climate action. However, as part of the healthcare industry, which is increasingly focusing on sustainability, it is likely that Fresenius Kabi Canada Ltd. is aware of the importance of addressing carbon emissions and may be exploring future initiatives to align with industry standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Fresenius Kabi Canada Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Fresenius Kabi Canada Ltd. is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Fresenius Kabi Canada Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Teligent, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Sandoz Canada Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Pfizer

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers